http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004214346-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
filingDate 2003-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_010a22ed59f3be5cf4bfc44e26ae04be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7164d71c74f6dc570779e9c6be855f57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a3b81bba468d2e9b84d4447662044c5
publicationDate 2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004214346-A1
titleOfInvention Diagnostic assay for anti-von willebrand factor cleaving protease ( ADAMTS13) antibodies
abstract This invention relates to a kit to be used in an assay system for determination of an anti-von Willebrand Factor-cleaving protease (“anti-vWF-cp”) antibody in a sample. The kit comprises vWF-cp and/or vWF-fragment(s) immobilized on a solid phase. The kit can be used in a method for determination of anti-vWF-cp antibodies from a patient, for the diagnosis of disorders associated with the occurrence of anti-vWF-cp-antibodies, and the differentiation of various forms of thrombotic microangiopathy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007015703-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8932820-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007275414-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011143369-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7923255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012159045-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009004673-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012255027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8088624-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11124787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010136589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006019431-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10233436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008096221-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9222942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9869683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10591490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8759018-B2
priorityDate 2003-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003228284-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6008335-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485

Total number of triples: 38.